Our Biotech Stock Watch List is our go to newsletter for key upcoming catalysts. Biotech stock catalysts include upcoming clinical data readouts and regulatory decisions (e.g. PDUFA dates) for a combination of small and large cap biotech stocks listed on NYSE and NASDAQ. This is delivered once...
Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).read more ...
The biotech stock lands on the Tech Leaders list as well. Biotech Stock Recovers ADMA Biologics was on a run — until Oct. 10 when its independent auditor unexpectedly resigned. The company kept its guidance for 2024 and 2025, but shares tumbled more than 16%. On Nov. 1, ADMA stock ...
Exicure(NASDAQ: XCUR) has acquired GPCR Therapeutics USA, a former subsidiary of GPCR Therapeutics, through a Share Purchase Agreement. Concurrently, the companies entered into a License & Collaboration Agreement requiring Exicure to pay milestone- and royalty-based fees on sales of GPCR’s technologi...
Founded in 2000, the biotech firm was listed on the New York Stock Exchange in 2007 and delisted in 2015 after its decision to be privatized. It just took 50 days for the company to get the greenlight from the China Securities Regulatory Commission (CSRC) to list on the A-share market....
The Nasdaq stock exchange is known for hosting some of the largest and most notable technology companies, but it also has a fairly substantial roster of biotech stocks. To access these, investors can buy IBBQ. "IBBQ tracks the Nasdaq Biotechnology Index, a nearly-three-decades-old index metho...
In biotech, sometimes it's the companies that aren't making a single dime that end up being the very best investments after a short time. For instance, Viking Therapeutics (NASDAQ: VKTX) doesn't yet have any revenue. But thanks to its ongoing clinical in
Because it’s not one of the more steady names on the list, the stock is far more volatile, too. The company went public at $17 a share in 2013, (but opened at $25.50). Two years later the stock was knocking on the door for $200 a share — but the volatility was just beginning...
If you don't watch these stocks with ninja-like patience you'll get a one-way ticket to Blowupville 😵 Here are the stocks I'm watching NOW!
List of the largest Biotech companies by market capitalization.The market capitalization sometimes referred as Marketcap, indicates the value of a publicly listed company.